SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-21-001591
Filing Date
2021-03-17
Accepted
2021-03-17 16:30:59
Documents
60
Period of Report
2021-01-31

Document Format Files

Seq Description Document Type Size
1 10-Q organicell_10q.htm 10-Q 416360
2 EXHIBIT 3.1 organicell_ex3-1.htm EX-3.1 966
3 EXHIBIT 31.1 organicell_ex31-1.htm EX-31.1 17138
4 EXHIBIT 31.2 organicell_ex31-2.htm EX-31.2 17318
5 EXHIBIT 32.1 organicell_ex32-1.htm EX-32.1 5881
6 EXHIBIT 32.2 organicell_ex32-2.htm EX-32.2 6059
7 GRAPHIC img001_v1.jpg GRAPHIC 213960
  Complete submission text file 0001829126-21-001591.txt   3262682

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE bpsr-20210131.xml EX-101.INS 422747
9 XBRL SCHEMA FILE bpsr-20210131.xsd EX-101.SCH 45122
10 XBRL CALCULATION FILE bpsr-20210131_cal.xml EX-101.CAL 40064
11 XBRL DEFINITION FILE bpsr-20210131_def.xml EX-101.DEF 160013
12 XBRL LABEL FILE bpsr-20210131_lab.xml EX-101.LAB 249745
13 XBRL PRESENTATION FILE bpsr-20210131_pre.xml EX-101.PRE 222667
Mailing Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140
Business Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 000-55008 | Film No.: 21750967
SIC: 3790 Miscellaneous Transportation Equipment